Simplex Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Simplex Trading’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,285	Closed	-$744K	–	7447
2017 Q4	$744K	Buy	+16,285	New	+$812K	0.03%	520
2017 Q2	–	Sell	-8,048	Closed	-$199K	–	7296
2017 Q1	$178K	Sell	8,048 -6,446	-44%	-$138K	0.01%	1302
2016 Q4	$273K	Sell	14,494 -2,026	-12%	-$49.6K	0.02%	858
2016 Q3	$495K	Sell	16,520 -14,311	-46%	-$445K	0.03%	512
2016 Q2	$1.19M	Buy	30,831 +15,706	+104%	+$652K	0.08%	230
2016 Q1	$576K	Buy	+15,125	New	+$527K	0.05%	392
2015 Q3	–	Sell	-11,597	Closed	-$509K	–	6636
2015 Q2	$618K	Buy	+11,597	New	+$616K	0.05%	340

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Simplex Trading's JUNO Position: Q1 2018 in Review

Simplex Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,285 shares — an estimated $744K sold.

Simplex Trading first reported a position in JUNO in Q2 2015 and held it in 7 quarters. The position peaked at $1.19M in Q2 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Simplex Trading reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Simplex Trading sold 16,285 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $744K.
Simplex Trading first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
Simplex Trading's Juno Therapeutics, Inc. position peaked at $1.19M in Q2 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.